Stocktoria

Ambev S.A. ABEV3.SA

BR · B3 (Brasil Bolsa) · XBSP · stock · Consumer Defensive · website

Ambev S.A. (ABEV3.SA) earns a Piotroski F-score of 8/9 (strong financial health). It pays a dividend yielding 8.10% (safety: at-risk). FY2025 revenue was $88.2B at a 17.6% net margin.

Chart by TradingView
8/9
Piotroski F — financial health
Altman Z″ — distress risk
132.0%
Dividend payout · at-risk
$16.29 as of 2026-06-01 · +22.3% 1y
$12.09$16.3252-wk

Price from month-end closes (Yahoo) — for reference, not real-time.

Market cap$252.8B
P / E16.3×
Net margin17.6%
Revenue trend · last 4y · up

How it ranks in Consumer Defensive · percentile among 43 companies

Piotroski Fstronger than 86%
Net marginstronger than 77%
Return on equitystronger than 51%
Revenue growthstronger than 21%

Percentile vs other Consumer Defensive companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 8/9 tests passed

FAQ

Is ABEV3.SA financially healthy?

Ambev S.A.'s Piotroski F-score is 8/9 (8–9 is excellent, 0–3 weak).

Does ABEV3.SA pay a dividend, and is it safe?

Yes. Ambev S.A. pays a dividend yielding about 8.10% with a 132.0% payout ratio, rated “at-risk” for safety.

How profitable is ABEV3.SA?

In FY2025, Ambev S.A. had a net margin of 17.6% and a return on equity of 17.6%.

Source: company filings via Yahoo Finance · BR · as of 2025-12-31. Figures in BRL; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.